These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34782911)

  • 1. Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box.
    Sgouros G; Frey E; Du Y; Hobbs R; Bolch W
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):18-29. PubMed ID: 34782911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.
    Sgouros G; Hobbs R; Josefsson A
    Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters.
    Sgouros G
    Semin Nucl Med; 2020 Mar; 50(2):124-132. PubMed ID: 32172797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Case for Dosimetry in Alpha-Emitter Therapy.
    Sgouros G
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S45-S46. PubMed ID: 31537496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides.
    Li WB; Bouvier-Capely C; Saldarriaga Vargas C; Andersson M; Madas B
    Radiat Environ Biophys; 2022 Nov; 61(4):579-596. PubMed ID: 36239799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Targeted Alpha Particle Therapy for Solid Tumors.
    Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.
    Hobbs RF; Howell RW; Song H; Baechler S; Sgouros G
    Radiat Res; 2014 Jan; 181(1):90-8. PubMed ID: 24502376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted and Nontargeted α-Particle Therapies.
    McDevitt MR; Sgouros G; Sofou S
    Annu Rev Biomed Eng; 2018 Jun; 20():73-93. PubMed ID: 29345977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery.
    Coll RP; Bright SJ; Martinus DKJ; Georgiou DK; Sawakuchi GO; Manning HC
    Mol Imaging Biol; 2023 Dec; 25(6):991-1019. PubMed ID: 37845582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system.
    Peter R; Sandmaier BM; Dion MP; Frost SHL; Santos EB; Kenoyer A; Hamlin DK; Wilbur DS; Stewart RD; Fisher DR; Vetter K; Seo Y; Miller BW
    Sci Rep; 2022 Oct; 12(1):17934. PubMed ID: 36289434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A persistent belief in radiopharmaceutical therapy.
    Sgouros G
    Med Phys; 2023 Jun; 50 Suppl 1():104-108. PubMed ID: 36774195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry for radiopharmaceutical therapy.
    Sgouros G; Hobbs RF
    Semin Nucl Med; 2014 May; 44(3):172-8. PubMed ID: 24832581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.
    Huclier-Markai S; Alliot C; Varmenot N; Cutler CS; Barbet J
    Curr Top Med Chem; 2012; 12(23):2642-54. PubMed ID: 23339760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Lee D; Li M; Bednarz B; Schultz MK
    Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
    Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Radiotherapy with Alpha-Particle Emitting Radionuclides Seminar, November 18, 2004, Cracow, Poland.
    Zalutsky MR; Petelenz B
    Nucl Med Rev Cent East Eur; 2004; 7(2):195. PubMed ID: 15968616
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient-specific alpha-particle dosimetry.
    Palm S; Elgqvist J; Jacobsson L
    Curr Radiopharm; 2011 Oct; 4(4):329-35. PubMed ID: 22202155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Alpha Therapy: Current Clinical Applications.
    Guerra Liberal FDC; O'Sullivan JM; McMahon SJ; Prise KM
    Cancer Biother Radiopharm; 2020 Aug; 35(6):404-417. PubMed ID: 32552031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
    Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
    Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.